prIME Oncology awarded Provisional Accreditation to provide medical education for physicians

prIME Oncology has been awarded Provisional Accreditation to provide continuing medical education for physicians by the Accreditation Council for Continuing Medical Education (ACCME) in the US. Provisional Accreditation is the standard status for initial, or first-time, applicants.

“This is an important step forward in the evolution of our organization and will further position [prIME Oncology] in the marketplace for continued growth and success”

"This is an important step forward in the evolution of our organization and will further position [prIME Oncology] in the marketplace for continued growth and success," said Dr. Nathan Kelly, Senior Director of Global Clinical Operations.

prIME Oncology's CME activities cover all types of solid tumors and hematologic malignancies and address prevention, diagnosis, treatment, surgical management, supportive care, palliation, and psychological care of patients with cancer-related illnesses. Multiple educational platforms are employed to impact change.

prIME Oncology offers:

• Congress review series that critically review rapidly-evolving primary data from large congresses held worldwide
• Satellite symposia at major national and international oncology and hematology meetings
• Stand-alone congresses featuring worldwide experts engaging learners in case studies and outcome discussions
• Interactive formats including on-demand video and audio
• Internet CME
• Print formats of expert presentations and summaries